Overview
I am interested in leveraging clinical data obtained through rigorous clinical research methods to improve outcomes for patients undergoing lung transplantation with my research up to this point primarily focusing on identifying abnormalities or patterns in disease processes.
While undergoing pulmonary and critical care medicine fellowship training at Duke, I became excited and passionate about taking care of cystic fibrosis patients, more specifically, those undergoing lung transplantation. I was surprised by the complexities of maintaining the balance between allowing the immune system to function in preventing infections and malignancies alongside its suppression to prevent lung allograft rejection. While rotating within Duke's lung transplant clinic I encountered many patients that, despite following care guidelines and maintaining this balance, would still develop chronic lung allograft dysfunction. It was challenging to see patients who had been given their lives back with a lung transplant start to go back down the path of dyspnea and loss of lung function that had brought them to consider transplant in the first place. This motivated me to learn more about lung transplantation with the hope of identifying new strategies that could help prevent patients from developing chronic lung allograft dysfunction.
Current Duke Appointments & Affiliations
Recent Scholarly Works
Measures of Personality and Early Post-Transplant Outcomes in Lung Transplant Recipients
Conference JOURNAL OF HEART AND LUNG TRANSPLANTATION · April 2026 Link to item CiteAbnormal spirometry 1 year after lung transplantation may identify patients at risk for chronic lung allograft dysfunction in a multicenter cohort.
Journal article JHLT Open · February 2026 BACKGROUND: Baseline lung allograft dysfunction (BLAD) is the failure to achieve predicted pulmonary function after lung transplantation. BLAD, as defined by abnormal spirometry at 12 months post-transplant (Spiro12M), has been associated with increased mo ... Full text Link to item CiteCD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohort.
Journal article J Heart Lung Transplant · September 2025 BACKGROUND: CD26/dipeptidyl peptidase 4 inhibitors (gliptins) target proinflammatory pathways that contribute to the development of chronic lung allograft dysfunction (CLAD). We analyzed longitudinal clinical data from 6 North American lung transplant cent ... Full text Link to item CiteRecent Grants
Lung Transplant Clinical Trial Network (LT-CTN)
ResearchResearch Scientist · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2028CYSTIC FIBROSIS FDTN GRANT #CC011-AD
ResearchProgram Director · Awarded by Cystic Fibrosis Foundation · 2016 - 2027Identifying acute lung allograft dysfunction in lung transplant recipients and evaluating its relationship in developing chronic lung allograft dysfunction
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2025 - 2027View All Grants